ObjectiveTo evaluate the impact of doxycycline on the expression of the human tetracycline gene in transgenic mice. Materials and Methods: We used the tet-on-dependent transgenic mouse line (Myc-tetO) which is the most widely used mouse model for the study of tetracycline-induced inflammation. The study was carried out by means of a novel transgenic mouse line, named, which contains the tetracycline-regulated promoter of the human tetracycline promoter. The expression of the human tetracycline promoter, the mouse tetracycline gene, and tetracycline-responsive elements (TRE) in transgenic mice was determined using the Tet-On system. The Tet-On system is a system for the monitoring the expression of genes in an experimental system. The expression of the Tet-On system was detected in both the transgenic mice and the wild type. Analysis of the Tet-On system was carried out using a quantitative real-time PCR method. Results: The expression of the Tet-On system was significantly decreased in the transgenic mice and increased in the wild type by almost 90%. The expression of the Tet-On system in the mouse tetracycline-responsive elements (TREs) was significantly increased in the tetracycline-responsive elements. The expression of the Tet-On system in the tetracycline-responsive elements of the wild type was significantly increased by 90%. The expression of the Tet-On system in the mouse tetracycline-responsive elements of the tetracycline-responsive elements of the wild type was significantly increased by 90%. Conclusions: The mouse tetracycline-inducible promoter system is useful for evaluating the expression of the human tetracycline promoter in transgenic mice and its expression in the mouse tetracycline-responsive elements of the Tet-On system.
Key messages1. Doxycycline (DOX) decreases the expression of the human tetracycline promoter in mice by approximately 30%, resulting in an increase of the expression of the mouse tetracycline promoter by approximately 90%. 2. Doxycycline is a synthetic tetracycline. DOX blocks the binding of tetracycline to its target site in the promoter. DOX may also cause changes to the expression of the mouse tetracycline promoter.
IntroductionTet-on-dependent transgenic mice are a good model to evaluate the impact of tetracycline on the expression of the human tetracycline gene. The tetracycline promoter in transgenic mice is regulated by the tetracycline hormone (tet) and its receptor (tetR) (, ). This promoter, which is located upstream of the transcriptional start sites of the tetracycline operon, is usually regulated by the promoter of the tetracycline operon, while its expression is induced by tetracycline (, ). The tetracycline receptor (tetR) is found in the promoter of the tetracycline operon, whereas the promoter of the tetR is regulated by the tetracycline receptor (tetR) (, ). In this study, we evaluated the impact of DOX on the expression of the human tetracycline gene and Tet-On system using the Tet-On system. To our best knowledge, this is the first study to evaluate the impact of DOX on the expression of the human tetracycline gene. In this study, we used the Tet-On system to determine the expression of the mouse tetracycline gene in transgenic mice. This study will help us to better understand the molecular mechanisms involved in the regulation of the human tetracycline gene in transgenic mice. We hope this study will contribute to the development of a new animal model for the study of tetracycline-induced inflammation.
$0.00
Discontinued/ resubmitted productPrescription required
ManufacturerAstraZeneca
Active Ingredient: Doxycycline
Synonyms: Doxycycline hyclate, doxycycline
Pharmacology: Pharmacodynamic
Chemical structure: pyrazine, chlordiazepone
Route: tablet
Strength: 150 mg
Excipients: gelatin, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, titanium dioxide, lactose, colloidal anhydrous silica
Therapeutic Class: Antibiotic
Indication: Respiratory infections in patients with advanced chronic obstructive pulmonary disease
Administration: Oral
Dosage: As required
Warnings: Warnings should be followed carefully before and after treatment with doxycycline hyclate capsules
Uses: The capsules are intended for oral administration.
Side Effects: May be gastrointestinal (e.g. diarrhea, nausea, abdominal pain).
Mode of Action: Doxycycline is an antibiotic of the tetracycline class and is most commonly used for the treatment of respiratory infections, including bronchitis and pneumonia. The main mechanism of action is that of inhibiting bacterial protein synthesis.
Drug Interactions: Doxycycline may interact with other drugs that may also be of concern.
Storage Conditions: Store in the original container at a temperature not exceeding 25° C. Keep away from direct sunlight and out of reach of children.
Contraindications: Hypersensitivity to the active substance or to other substances in the formulation
Dosage and Administration: The dosage is based on the severity of the infection and the patient's age. The usual initial dose is 150 mg taken once daily for 7 to 14 days.
Warnings: The capsules are intended for oral administration.
Drug Interactions: Doxycycline may interact with other drugs that may also be concern.
Contraindications: Hypersensitivity to the active substance or to other substances in the formulation.
Doxycycline is used for the treatment of various bacterial infections like that of chest, lung or nose (Ex. bronchitis, pneumonia, sinusitis), urinary tract (Ex. cystitis, urethritis), skin (Ex. acne), eyes or sexually transmitted diseases (Ex. gonorrhoea, syphilis, chlamydia).
It is also used to treat fevers associated with louse or tick bites and malaria (when chloroquine is ineffective). It can also be used to prevent certain infections like scrub typhus (a disease carried by small insects), Rocky Mountain spotted fever, travellers’ diarrhoea, malaria and leptospirosis.
Doxycycline:Tetracycline antibiotics
Doxycycline works by inhibiting the growth and replication of bacteria. It does this by binding to the bacterial ribosome, preventing the synthesis of proteins that are essential for the bacteria's survival.
Consult your doctor if you experience:
Since 1983, Doxycycline has been the subject of extensive research and approval by the FDA. As a drug of global public health importance, it is a sought after for its effectiveness in treating various medical conditions, particularly those involving bacterial infections. As a result, it has become a cornerstone in the treatment of bacterial infections such as acne (also known as rosacea), malaria (insomnia) and gonorrhoea (gonorrhea). Doxycycline works by inhibiting the replication and growth of bacteria and thus reducing their ability to produce proteins that are essential for their survival.
What is the use of doxycycline?
Doxycycline is used to treat:
How do I take doxycycline?
The recommended dose of doxycycline is 50mg once daily before taking the medication, which can be adjusted if necessary. If the medicine is broken down by the stomach, your doctor can adjust the dose accordingly. Doxycycline is usually taken with a meal or snack as the background medication.
What if I forget to take a dose of doxycycline to treat the next time can be taken as if it were Tdoxy?
If you take more doxycycline, you may not get the next dose, but if you take doxycycline more than the recommended dose, you may not get the next dose.
Can I take doxycycline if I take other medications?
Doxycycline can affect the medication's absorption. Check the maximum strength of the medication and your doctor's advice when determining if you should take this product.
Can I eat a doxycycline tablet if I'm pregnant?
Doxycycline is in pregnant and breast-feeding supplements are not recommended during the span of your baby's normally. If you're planning a pregnancy or are taking any other medication, it's advisable to avoid using doxycycline during the period.
Should I take doxycycline? If you're planning a pregnancy or are considering any sort of medication, you should avoid using doxycycline during the period.The United States has made the first shipment of a new antibiotic from South Africa to the African Union. The shipment arrived on Monday, and is expected to be completed by the end of the month. The shipment of doxycycline was made at the Customs and Border Patrol’s international office in Johannesburg.
According to the United States, the shipment was made by the South African Customs Service, which is the third largest agency in the world, which has its main headquarters in Cape Town.
The Customs Service is responsible for inspecting pharmaceuticals in most of South Africa, but the South African Customs Service is responsible for other goods, which are also seized and sold at ports and the international markets. The United States and South Africa have a total value of US$ 5 million and US$ 8 million, respectively. This is the fourth shipment of doxycycline from South Africa to the South African Customs Service, the last being in May 2018.
The first shipment was made on March 8, and the first shipment on Sunday, March 30, 2018.
VIDEOSource:
Article continues after videoThe United States has made the first shipment of a new antibiotic from South Africa. The shipment arrived on Monday, March 30, 2018, and is expected to be completed by the end of the month. The US Customs Service is responsible for inspecting pharmaceuticals in most of South Africa, but the South African Customs Service is responsible for other goods, which are also seized and sold at ports and the international markets.